Vision Medicines Company Profile

13:43 EDT 18th March 2018 | BioPortfolio

Vision Medicines, Inc. is a privately held, clinical-stage, biopharmaceutical company committed to developing innovative therapies for patients suffering from blinding retinal diseases. Founded in 2013, the company is building a differentiated ophthalmology pipeline to treat retinal diseases, including orphan indications for which there are no treatments.

News Articles [1126 Associated News Articles listed on BioPortfolio]

Young woman presents with acute-onset unilateral vision loss

A 27-year-old marketing professional was seen at Tufts Medical Center emergency department with new-onset vision changes in the right eye. She first noted a change in vision approximately 30 hours bef...

Pixium Vision announces successful implantation and activation of PRIMA Bionic Vision System

Pixium Vision (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today the world’s fir...

French Biotech Restores Vision in Humans with Subretinal Implant

Pixium Vision has successfully restored vision in three patients with age-related macular degeneration (AMD) using an implanted wireless device, offering significant improvements to their quality of l...

SEA Vision becomes a partner of the Marchesini Group

The Marchesini Group has signed a 48% acquisition of SEA Vision, a leading creator of vision and inspection systems used in quality control and drug counterfeiting

New NAVRISK VISION 2.0 Release

"The new NAVRISK VISION Release 2.0 provides new usability improvements that streamline key task management, increase productivity and simplify functionality across all NAVRISK VISION platforms," ...

New smartphone app may help patients take better care of their vision at home

Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to resea...

Middle-age man experiences unilateral, episodic, blurred vision

A 50-year-old man was referred to the New England Eye Center for 2 years of episodic blurry vision and right eye irritation. He previously saw an ophthalmologist a year ago who attributed his blurry v...

Antares Vision To Open Software Development Center In Ireland

NewsThe facility, which will create more than 50 jobs in computer vision and artificial intelligence over five years, will focus on developing new software tools utilizing deep learning as it relates ...

Drugs and Medications [139 Associated Drugs and Medications listed on BioPortfolio]

Terbinafine hydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...

Cimetidine [Walgreen Company]

Walgreen Co. Cimetidine 200 Drug Facts

Dg health heartburn relief [Dolgencorp, LLC]

Dolgencorp, LLC Heartburn Relief Drug Facts

Acid reducer [Rite Aid Corporation]

Rite Aid Corporation Acid Reducer Drug Facts

Smart sense acid reducer [Kmart Corporation]

Kmart Corporation Acid Reducer Drug Facts

PubMed Articles [572 Associated PubMed Articles listed on BioPortfolio]

Essential medicines availability is still suboptimal in many countries: A scoping review.

To identify uses of WHO Model list of essential medicines (EM) and summarize studies examining essential medicines (EM) and national EM lists (NEMLs).

Acknowledgement to Reviewers of Medicines in 2016.

The editors of Medicines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...].

Ethical responsibilities of pharmacists when selling complementary medicines: a systematic review.

The widespread sale of complementary medicines in community pharmacy raises important questions regarding the responsibilities of pharmacists when selling complementary medicines. This study reviews t...

Announcing the 2018 Medicines Travel Award for PostDocs.

For the Medicines Travel Award 2018, we received a total of 41 applications from all over the world, of a wery high quality[...].

Announcing the 2017 Medicines Travel Award for PostDocs.

For the Medicines Travel Award 2017, we received in total 72 applications from all over the world, most of which were of a very high quality.[...].

Clinical Trials [1032 Associated Clinical Trials listed on BioPortfolio]

Low-vision Rehabilitation Program for Low-vision Patients and Care Givers

To evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP).

Cross-Over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus

Involuntary oscillations of the eyes (nystagmus) impairs vision so that affected patients, who have neurological disorders such as Multiple Sclerosis (MS) , cannot read or watch TV. Two me...

Low Vision Intervention Trial II (LOVIT II)

This study will determine if the interdisciplinary team low vision rehabilitation program is more effective than basic low vision care provided by an optometrist working alone in improving...

Safety Study Looking at the Effects of Stendra on Vision

The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.

VA Low Vision Intervention Trial

The primary purpose of this research study is to evaluate the effectiveness of a new outpatient low vision rehabilitation program that is targeted to serve legally blind veterans with cent...

Companies [1306 Associated Companies listed on BioPortfolio]

Vision Medicines

Vision Medicines, Inc. is a privately held, clinical-stage, biopharmaceutical company committed to developing innovative therapies for patients suffering from blinding retinal dis...

Vision Medicines, Inc.

European Directorate for the Quality of Medicines

The EDQM was created in 1996 and is a Directorate of the Council of Europe. Its premises have been especially designed for its various activities. Today the EDQM is organised into nine administrative...

Davis Vision

Headquartered in Plainview, N.Y., Davis Vision is one of America's leading vision benefits companies, providing comprehensive vision benefits for nearly 50 years. More than 55 million individuals nati...

Medicines Company

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals wor...

More Information about "Vision Medicines" on BioPortfolio

We have published hundreds of Vision Medicines news stories on BioPortfolio along with dozens of Vision Medicines Clinical Trials and PubMed Articles about Vision Medicines for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vision Medicines Companies in our database. You can also find out about relevant Vision Medicines Drugs and Medications on this site too.

Quick Search


Relevant Topic

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Corporate Database Quicklinks

Searches Linking to this Company Record